Hilar Cholangiocarcinoma

specific

A carcinoma that arises from the junction, or adjacent to the junction, of the right and left hepatic ducts.

27

Centers

0

Active Trials

$323K

Cancer Funding

Top Centers for Hilar Cholangiocarcinoma(27)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.7
2
NCI Comprehensive
51.2
3
NCI Comprehensive
51.2
4
NCI Comprehensive
51.2
5
NCI Comprehensive
51.2
651.2
7
NCI Comprehensive
51.2
8
NCI Comprehensive
51.2
9
NCI Comprehensive
51.2
10
NCI Comprehensive
51.2
11
NCI Comprehensive
51.2
12
NCI Clinical
51.2
13
NCI Comprehensive
51.2
14
NCI Comprehensive
51.2
1551.2
16
NCI Comprehensive
51.2
17
NCI Comprehensive
51.2
1851.2
1951.2
2051.2
2151.2
22
NCI Comprehensive
51.2
2351.2
2451.2
2551.2
2651.2
2751.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →